Manuel Saldivia (@ampliconx) 's Twitter Profile
Manuel Saldivia

@ampliconx

Drug discovery. For external use only.

ID: 172859010

linkhttp://www.shake-beforeuse.com/ calendar_today30-07-2010 20:01:15

485 Tweet

155 Followers

252 Following

Manuel Saldivia (@ampliconx) 's Twitter Profile Photo

Let's Twist Again! šŸ’ƒšŸ•ŗ Thrilled to see this collaborative effort toward a cure for Chagas disease science.org/doi/10.1126/sc…

Manuel Saldivia (@ampliconx) 's Twitter Profile Photo

Collaboration between academia and industry is critical for bridging the gap between theory and application. It fosters innovation and translates knowledge into solutions that benefit patients. #research #innovation #healthcare nature.com/articles/d4157…

drug hunter (@drughunter_com) 's Twitter Profile Photo

Recently, Novartis disclosed a new class of brain-penetrant, covalent agents against kinetoplastid parasites in Science. Why it matters, how it works, and why it’s interesting in the full article: drughunters.com/461lMsB

Recently, Novartis disclosed a new class of brain-penetrant, covalent agents against kinetoplastid parasites in Science. 

Why it matters, how it works, and why it’s interesting in the full article: drughunters.com/461lMsB
Trends in Parasitology (@trendsparasitol) 's Twitter Profile Photo

Drs Manuel Saldivia, Ana Lima & Jeremy Mottram highlight a promising pipeline of preclinical drug candidates for #visceral #leishmaniasis & chronic #Chagas’ disease published in Science Translational Medicine by Susan Wyllie Manu De Rycker & colleagues. York Biomedical Research Institute Novartis UFRJ cell.com/trends/parasit…

Drs Manuel Saldivia, Ana Lima &amp; <a href="/Mottram_group/">Jeremy Mottram</a> highlight a promising pipeline of preclinical drug candidates for #visceral #leishmaniasis &amp; chronic #Chagas’ disease published in <a href="/ScienceTM/">Science Translational Medicine</a> by Susan Wyllie <a href="/MDR_DDU/">Manu De Rycker</a> &amp; colleagues. <a href="/YBRI_UoY/">York Biomedical Research Institute</a> <a href="/Novartis/">Novartis</a> <a href="/ufrj/">UFRJ</a> 

cell.com/trends/parasit…
ACS Publications Bio & Med Chem Content (@acsbiomed) 's Twitter Profile Photo

šŸ“¢ Call for Papers šŸ“¢This new Special Issue from ACS Infectious Diseases will showcase the latest tuberculosis biology and medicinal chemistry research. Submit your manuscript by October 15, 2024. šŸ”— go.acs.org/8Wh.

šŸ“¢ Call for Papers šŸ“¢This new Special Issue from ACS Infectious Diseases will showcase the latest tuberculosis biology and medicinal chemistry research. Submit your manuscript by October 15, 2024. šŸ”— go.acs.org/8Wh.
Novartis News (@novartisnews) 's Twitter Profile Photo

Novartis and Medicines for Malaria Venture (MMV) announce positive data from the trial of a treatment for the tiniest babies with #malaria. This brings us one step closer to ensuring all people can access an effective malaria treatment #WorldMalariaDay #NovartisNews EDCTP go.novartis.social/3Wk96eC

The Fidock Lab (@fidocklab) 's Twitter Profile Photo

Congrats to Lab member John Okombo on publishing "Towards next-generation treatment options to combat Plasmodium falciparum malaria" in Nature Reviews Microbiology. Take a look! doi.org/10.1038/s41579…

Jayanta Haldar (@jayanta_amr) 's Twitter Profile Photo

ACS Infectious Diseases is pleased to bring a Virtual Special Issue on "One Health and Vector Borne Parasitic Diseases", led by Felix (AE) along with Paola and Anabela (Guest Editors)! Covers articles across diverse topics! ACS Publications Bio & Med Chem Content ACS Publications pubs.acs.org/page/aidcbc/vs…

ACS Infectious Diseases is pleased to bring a Virtual Special Issue on "One Health and Vector Borne Parasitic Diseases", led by Felix (AE) along with Paola and Anabela (Guest Editors)! Covers articles across diverse topics! <a href="/ACSBioMed/">ACS Publications Bio & Med Chem Content</a> <a href="/ACSPublications/">ACS Publications</a> 
pubs.acs.org/page/aidcbc/vs…